sunny balwani

Latest

  • Ramesh "Sunny" Balwani, former president and chief operating officer (COO) of Theranos and ex-boyfriend of founder Elizabeth Holmes, leaves after the opening day of his federal trial for wire fraud and conspiracy to commit wire fraud was postponed due to coronavirus disease (COVID-19) exposure in the courtroom in San Jose, California, U.S. March 16, 2022.  REUTERS/Brittany Hosea-Small

    Former Theranos COO Sunny Balwani sentenced to 12 years and 11 months in prison

    by 
    Karissa Bell
    Karissa Bell
    12.07.2022

    Ramesh “Sunny” Balwani, Theranos’ former chief operating officer, has been sentenced for his role in defrauding Theranos' former patients and investors.

  • Ramesh "Sunny" Balwani, former president and chief operating officer (COO) of Theranos and ex-boyfriend of founder Elizabeth Holmes, leaves after the opening day of his federal trial for wire fraud and conspiracy to commit wire fraud was postponed due to coronavirus disease (COVID-19) exposure in the courtroom in San Jose, California, U.S. March 16, 2022.  REUTERS/Brittany Hosea-Small

    Former Theranos COO Sunny Balwani found guilty of all charges

    by 
    Karissa Bell
    Karissa Bell
    07.07.2022

    Ramesh “Sunny” Balwani, Theranos’ former chief operating officer, has been found guilty of all charges in his criminal trial.

  • Justin Sullivan via Getty Images

    The Elizabeth Holmes Theranos trial will start next summer

    by 
    Richard Lawler
    Richard Lawler
    06.28.2019

    After the scandal, the book, the podcasts and the documentary, the Theranos debacle is finally going to court -- in 2020. U.S. District Court Judge Edward Davila set the start date of co-founder Elizabeth Holmes' criminal trial for August 4th of next year, with jury selection kicking off the week before. She's been indicted -- along with Theranos president Ramesh "Sunny" Balwani -- on 11 counts of wire fraud and conspiracy to commit wire fraud. After the SEC announced charges last year Theranos finally announced it would shut down, well after it was exposed in 2016 for promoting "fingerprick" blood test technology that didn't work as promised and it largely wasn't using. In pretrial motions, lawyers representing Holmes targeted communications between regulators and a Wall Street Journal reporter and Bad Blood author John Carreyrou. Bloomberg reports they claimed he "was exerting influence on the regulatory process in a way that appears to have warped the agencies' focus on the company and possibly biased the agencies' findings against it."